Xuemei Feng
-
- Hepatitis C virus research 7
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 5
-
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 3
-
- Long-Term Effects of COVID-19 3
-
- Virus-based gene therapy research 2
-
- Research in Cotton Cultivation 2
- Journals
- Journal of Controlled Release (1 paper)Frontiers in Immunology (5 papers)European Journal of Immunology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xuemei Feng
29 papers receiving 259 citations
Peers
Comparison fields: 5 of 66
- Hepatology 41
- Infectious Diseases 64
- Immunology 63
- Epidemiology 57
- Molecular Biology 104
Countries citing papers authored by Xuemei Feng
This map shows the geographic impact of Xuemei Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Feng more than expected).
Fields of papers citing papers by Xuemei Feng
This network shows the impact of papers produced by Xuemei Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Feng. The network helps show where Xuemei Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuemei Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 53 | |
| 12 | 2021 | 40 | |
| 13 | 2021 | 3 | |
| 14 | 2020 | 6 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 40 | |
| 17 | 2017 | 18 | |
| 18 | 2017 | 3 | |
| 19 | 2016 | 5 | |
| 20 | 1996 | 1 |
About Xuemei Feng
Xuemei Feng is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 31 papers that have together received 264 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers), Liver Disease Diagnosis and Treatment (3 papers), Long-Term Effects of COVID-19 (3 papers), Virus-based gene therapy research (2 papers) and Research in Cotton Cultivation (2 papers). The work is most often cited by research in Hepatology (41 citations), Infectious Diseases (64 citations) and Immunology (63 citations). Xuemei Feng has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Hu Wang, Dongliang Yang, Mengji Lu, Jia Liu, Ulf Dittmer, Yinping Lu, Baoju Wang, Xuecheng Yang, Xianghui Li and Xiangli Guo. Their work appears in journals such as Journal of Controlled Release, Frontiers in Immunology and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.